The Group’s Businesses and Objectives

Structure

MiLOC Group Limited is holding company of a pharmaceutical and healthcare service group which will be based primarily in Hong Kong, Macau and the PRC.

The Group will be principally engaged in three major business development opportunities relating to Traditional Chinese Medicine (“TCM”):

(i) The research and development of TCM specifically for pandemic diseases;

(ii) The sale and distribution of TCM;

(iii) The development of nationwide network of modernized TCM clinics and hospitals
in Hong Kong, Macau and the PRC.

It is the Group’s aim to explore the potential of TCM by introducing reliable TCM drugs to the market, focusing initially on Hong Kong, the PRC and Macau with the view to further expansion in South East Asia, and providing high quality modernised TCM healthcare services in Hong Kong, Macau and the PRC. The Group intends to promote a true TCM health care integrated delivery model from primary care to tertiary care.

The Group’s three businesses will complement each other and will form a vertically-integrated TCM medical network to provide TCM products and healthcare services under the brand name “MiLOC” in the pursuit of this aim. The pronunciation of “MiLOC” is similar to the pronunciation of the Chinese characters “美樂”, the Chinese name of the Group, which means well-being, beauty and happiness in Chinese.